Dietary Supplement : Applicants who voluntarily signed the Consent for Human Application Test on Visit 1 (screening) will be deemed suitable according to the selection/exclusion criteria. The selected

2 trials

Sponsors

Chonnam National University Hospital

Phase 3

A 24 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Mixtured Probiotics(KLP301) on Improvement of Cognitive Function

Active, not recruitingKCT0011796

Chonnam National University Hospital

Start: 2024-09-24Target: 80Updated: 2026-04-14

Unknown Phase

A randomized, double-blind, placebo-controlled to evaluate functionality and safety of KL-P301 in adult with mild cognitive impairment

RecruitingKCT0009453

Chonnam National University Hospital

Start: 2023-04-17Target: 100Updated: 2026-03-30